Stay updated on Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial
Sign up to get notified when there's something new on the Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial page.

Latest updates to the Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedA location spelling is corrected so the Parramatta, New South Wales site name is consistent. The page’s revision/version label is updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check25 days agoChange DetectedRevision v3.5.2 was added and revision v3.5.0 was removed.SummaryDifference0.0%

- Check54 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check61 days agoChange DetectedRevision: v3.4.3 added; Revision: v3.4.2 removed.SummaryDifference0.0%

- Check89 days agoChange DetectedAdded Revision: v3.4.2 and removed the government funding lapse notice (v3.4.1). These are administrative updates and do not affect the study details or user-facing content.SummaryDifference0.2%

- Check97 days agoChange DetectedThe page displays a new site notice about a lapse in government funding and adds a revision tag for v3.4.1, replacing v3.4.0; these are general site maintenance updates and do not alter the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial page.